Chugai Pharmaceutical

This is the first study in people to test a new drug called AUBE00 for patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might…

This is the first study in people testing a new drug called ALPS12 for extensive stage small cell lung cancer that has returned after prior treatment. The main goals are to find a safe dose and see how the body handles the drug, while also checking for early signs that it might s…

This study is testing whether an experimental drug called DONQ52 can help people with celiac disease who still experience intestinal damage and symptoms despite following a gluten-free diet. The trial will involve 92 participants who will receive either DONQ52 or a placebo for 27…